Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine
Journal of Clinical Investigation · 02.02.2026 · 136 (3)
DOI: 10.1172/jci200920 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.02.2026. Verfasst von Alice Bernard-Tessier und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Precision Medicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metastatic hormone-sensitive prostate cancer (mHSPC) is a clinically and molecularly heterogeneous disease. Recent insights into the biology underlying disease presentation, volume of disease, and response to therapies are starting to point toward biomarkers to improve selection for intensified and deintensified treatment strategies. In addition, the therapeutic landscape is rapidly changing, with new biomarker-driven studies targeting genotype (e.g., BRCA or PTEN mutant) and phenotype (e.g., prostate-specific membrane antigen status) in development for mHSPC. A better understanding of tumor heterogeneity, clonal evolution, and metastatic homing in prostate cancer will hopefully inform future strategies for local and systemic disease control, personalized monitoring strategies, and improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Gustave Roussy, Département de médecine oncologique, Villejuif, France.
Zitieren
APA
Bernard-Tessier, A., & Beltran, H. (2026). Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine. Journal of Clinical Investigation, 136(3). https://doi.org/10.1172/jci200920
Vancouver
Bernard-Tessier A, Beltran H. Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine. Journal of Clinical Investigation. 2026;136(3). doi:10.1172/jci200920
BibTeX
@article{BernardTessier2026,
author = {Bernard-Tessier, Alice and Beltran, Himisha},
title = {Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {3},
doi = {10.1172/jci200920}
}
EUVIMED